Synthesis of novel targeted pro-prodrugs of anthracyclines potentially activated by a monoclonal antibody galactosidase conjugate (part 1)
- 30 September 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (9) , 1093-1096
- https://doi.org/10.1016/s0960-894x(00)80625-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancerBioorganic & Medicinal Chemistry Letters, 1991
- Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugatesBioconjugate Chemistry, 1991
- (Acyloxy)alkyl carbamate prodrugs of norfloxacinJournal of Medicinal Chemistry, 1991
- Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2Journal of Medicinal Chemistry, 1990
- Carboxypeptidase-mediated release of methotrexate from methotrexate .alpha.-peptidesBiochemistry, 1989
- (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranesJournal of Medicinal Chemistry, 1988
- Human β-glucuronidase. Studies on the effects of pH and bile acids in regard to its role in the pathogenesis of cholelithiasisBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- A novel connector linkage applicable in prodrug designJournal of Medicinal Chemistry, 1981
- An alkali-labile substituted benzyloxycarbonyl amino-protecting groupJournal of the Chemical Society, Chemical Communications, 1973
- Eine neue Methode zur Synthese von Glykosiden der Phenole 1 ).Berichte der deutschen chemischen Gesellschaft (A and B Series), 1933